Literature DB >> 2153261

Site, size, and tumour involvement of resected extrapulmonary lymph nodes in lung cancer.

K Kayser1, S Bach, H Bülzebruck, I Vogt-Moykopf, G Probst.   

Abstract

A prospective study was performed analyzing resected extrapulmonary lymph nodes of 544 operated lung carcinoma patients. Volume of lymph nodes was determined by weight. Lymph nodes were cut in serial sections 300 microns thick, and the volume of tumour metastasis in each resected lymph node was computed measuring the tumourous area in the lymph node sections. The following results were obtained: Percentage of resected lymph nodes varied with lymph node site and site of the primary lung cancer. Hilar lymph nodes were resected in 50% of the patients, lymph nodes of the main and stem bronchi in 57% and 63%, respectively. Tumour metastases were found in 10%-15% of the resected lymph nodes. The size of the lymph nodes varied to a large amount and was found to be independent of the lymph node site if no metastases could be detected. Lymph nodes measuring less than 0.1 ccm were tumour infiltrated in 9% (77/706 lymph nodes), large lymph nodes (greater than 10 ccm) in 62% of the cases (20/32). Tumourous involved lymph nodes of the main bronchus were found more frequently in cases of central localized lung cancer compared to carcinoma arising from the peripheral lung, where the opposite was seen in subaortal located lymph nodes. The percentage of lymph node involvement and size of tumour infiltrated lymph nodes was found to be independent of tumour cell type. Size of resected lymph nodes is not a reliable parameter for estimating existence of tumour infiltrations.

Entities:  

Mesh:

Year:  1990        PMID: 2153261     DOI: 10.1002/jso.2930430112

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Mediastinal lymphatic drainage from pulmonary lobe based on CT observations of histoplasmosis: implications for minimal N2 disease of non-small-cell lung cancer.

Authors:  Koji Takahashi; William Stanford; Edwin Van Beek; Brad Thompson; Brian Mullan; Yutaka Sato
Journal:  Radiat Med       Date:  2007-10-26

2.  Skip metastasis and hidden N2 disease in lung cancer: how successful is mediastinal dissection?

Authors:  N Tsubota; M Yoshimura
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Optimising TNM Staging of Patients with Prostate Cancer Using WB-MRI.

Authors:  Vassiliki Pasoglou; Nicolas Michoux; Bertrand Tombal; Frédéric Lecouvet
Journal:  J Belg Soc Radiol       Date:  2016-11-19       Impact factor: 1.894

Review 4.  Nodal staging.

Authors:  Skandadas Ganeshalingam; Dow-Mu Koh
Journal:  Cancer Imaging       Date:  2009-12-24       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.